147Th Meeting of the Board of Directors 10.30Am, Thursday 6 May 2021 by Teams

1 147th Meeting of the Board of Directors 10.30am, Thursday 6 May 2021 By Teams AGENDA ITEM Purpose Presented by Category Time 10 General business mins Apologies for absence and To receive and record apologies for Andy Trotter 1 declaration of any conflicts of absence and request and record any Governance Chair interest declarations of interest Minutes of the Board of To approve the minutes of the last Andy Trotter 2 Directors’ Meeting held on 4 Governance meeting Chair p3 March 2021 Matters arising To confirm actions allocated at Andy Trotter 3 • No new actions agreed at previous meetings have been Governance Chair March Meeting completed To accept the BAF and consider whether the framework continues to Andy Trotter 4 Board Assurance Framework Governance provide sufficient assurance to the Chair p11 board Governance and Strategy 90 mins To note the developments within the Matthew Trainer, 5 Chief Executive Report trust and in the local health Strategy Chief Executive p28 economy. Iain Dimond, Operational update and Quality and 6 To note the update Chief Operating integrated performance report Performance p32 Officer Matthew Trainer, Chief Executive/ Oxleas Strategy 2021-24 – Rachel Clare 7 To note Strategy implementation Evans, Director of p79 Strategy and People Jane Wells, 8 GL – Serious Incident Report To note Director of Governance p101 Nursing Rachel Clare Evans, Director of 9 Equality Diversity System To approve Governance Strategy and p105 People Rachel Clare Evans, Director of 10 Annual Staff Survey report To note Governance Strategy and p120 People Azara Mukhtar, Annual report, quality report and Director of 11 annual accounts and To agree sign off process Finance/Sally Governance p128 NHS I/E self-certification process Bryden, Trust Secretary Sally Bryden, 12 Board review report To agree Governance p131 Trust Secretary Page 1 of 2 2 147th Meeting of the Board of Directors 10.30am, Thursday 6 May 2021 By Teams AGENDA Committee reports 20 mins Yemisi Gibbons, Performance and Quality To note the contents of the report Quality and 13 Non Executive Assurance Committee and agree any strategic implications performance p137 Director Amlan Basu, Quality Improvement and To note the contents of the report Quality and 14 Non Executive Innovation Committee and agree any strategic implications performance p147 Director Jo Stimpson, To note the contents of the report Financial strategy 15 Business Committee Non Executive and agree any strategic implications and performance p150 Director Jo Stimpson, To note the contents of the report Strategic 16 Partnership Committee Non Executive and agree any strategic implications partnerships p167 Director Suzanne Shale, To note the contents of the report Strategy and 17 Infrastructure Committee Non Executive and agree any strategic implications performance p169 Director Nina Hingorani- To note the contents of the report Crain, 18 Workforce Committee People strategy and agree any strategic implications Non Executive p171 Director Steve Dilworth To note the contents of the report 19 Audit and Risk Assurance report Non Executive Governance and agree any strategic implications p174 Director Board reports 15 mins Information relating to the experience of staff and patients and Andy Trotter Quality and staff 20 Board visits reports assess impact on delivery of trust Chair engagement p177 objectives Andy Trotter 21 Council of Governors update To note the contents of the report Chair Governance p186 ANY OTHER BUSINESS REVIEW EFFECTIVENESS OF MEETING DATE OF NEXT MEETING The next Board of Directors Meeting will take place on: Thursday 1 July at 10.30am Page 2 of 2 3 Board of Directors Item 2 6 May 2021 Enclosure 2 Report Title Minutes of the Board of Directors’ Meeting held on 4 March 2021 Author Susan Owen, Risk and Governance Manager Accountable Director Andy Trotter, Chair Confidentiality/ Public FOI status Report Summary Minutes of the Board of Directors’ meeting held on 4 March 2021 What is the purpose For approval of bringing this paper to the Board meeting? Eg for information/for decision etc Recommendation The Board is asked to agree the minutes as a true record of the meeting. Link to trust strategy The minutes cover the trust strategy approval. Link to Board The minutes include information on the BAF. Assurance Framework Please summarise implications in the report for: Quality Discussions on this are included in the minutes Finances Discussions on this are included in the minutes Equality analysis Discussions on this are included in the minutes Service users/ Issues relating to service users/carers and staff are included in the minutes carers/staff 4 145th Meeting of the Board of Directors Minutes of the meeting held on Thursday 4 March 2021 Virtual meeting held via MS Teams Board of Directors Andy Trotter Trust Chair Steve Dilworth Non-executive Director Jo Stimpson Non-executive Director Suzanne Shale Non-executive Director Yemisi Gibbons Non-executive Director Amlan Basu Non-executive Director Steve James Non-executive Director Matthew Trainer Chief Executive Iain Dimond Chief Operating Officer Dr Ify Okocha Medical Director Rachel Evans (RCE) Director for Strategy and People Azara Mukhtar Director of Finance Jane Wells Director of Nursing Neil Springham Director of Therapies In attendance Sally Bryden Trust Secretary and Associate Director of Corporate Affairs Rachel Evans (RTE) Director of Estates and Facilities Alison Furzer (AFu) Director of Informatics Tom Clark Deputy Medical Director Abi Fadipe (AFa) Deputy Medical Director Susan Owen Risk and Governance Manager (minutes) Members of the Council of Governors in attendance Ray Warburton Public: Rest of England Sue Sauter (SSa) Public: Bexley Lesley Smith Service user/carer: Bexley Adult Steve Pleasants Service user/carer: Bromley Adult Item Subject Action 1 Apologies for absence Noted • Nina Hingorani-Crain, Non-executive Director Declarations of interest • None declared. 2 Minutes of last meeting Approved Item 9: To be amended to read as ‘The RCA does not require us to find a single cause, and often there will be several root causes in a complex system.’ Pending this amendment and other amendments agreed in advance of the meeting, the minutes of the meeting on 14 January 2021 were declared as an accurate record. 3 Matters arising Noted 2021-01/#1: The incident investigation panel have reviewed the CH report. This will be reported to the March Performance and Quality Assurance Committee (PQAC). Nationally, early adopters are being taken forward on the new NHSE Patient Safety Incident Response Framework (replacing the current Serious Incident Framework in 2022). We aim to update on the national plans for this at a board strategy meeting in June. 2021-01/#2: It was noted that the capital expenditure paper was circulated to the board following the January 2021 meeting, and the board unanimously agreed by email. Page 1 of 7 5 Item Subject Action 4 Board Assurance Framework SD responded to the question from governor RW on the longevity of some of the risks. A risk is an event that has not yet occurred but could have adverse impact if it did, so it needs attention now. For some of the risks that have remained for over six years, the risk description and the context has changed, so the risk is different to when it was originally raised. The solution would be close the risk and re-open as a new risk every few years. We also need to consider whether the risk should be tolerated. The Board were very positive about the new format for the Board Assurance Framework. 5 Chief Executive’s Report Noted MT presented the Chief Executive’s report. We are moving in a positive direction with regard to Covid-19 operational pressures. The roll out of the vaccine programme is having an impact and we are looking at recovery tasks going forward. The Shadow Executive is working well; the team have access to the full set of papers and meet with MT to discuss and feed into the decision-making process. Positive work is being taken forward on Building a fairer Oxleas and this supports the trust strategy. Lawrence Mack has joined the trust as Director of Forensic and Prison Services, Azara Mukhtar has been appointed substantively as Director of Finance, and Neil Springham has commenced as Director of Therapies. The White Paper on integrated care proposes removing some of the legislation on competition but it would be some time before this is enacted into statute. The trust is undertaking more work on partnerships with health and social care partners. The reform of the Mental Health Act is a positive development on choice and autonomy. We will need to consider the operational and clinical implications, including local authority partners. MT thanked the Communications Team for their work on the Sky News item, as this brings to life the challenges clinical colleagues face. 6 Operational update and integrated performance report ID presented the operational update and integrated performance report. This includes the directorate level operational report plus a revised set of metrics. Covid-19 update A re-surge of Covid-19 in January and February has an impact on staffing in in-patient services and on the prison population, but absences are not to same level as the first wave. The re-surge has now receded. The percentage of clinically extremely vulnerable staff unable to work has been higher in the last couple of weeks. The first dose vaccination clinics for staff have now finished. We have also vaccinated selected cohorts of in-patient groups. Operational performance We have experienced an increase in demand in district nursing, cardiac and respiratory services, and this is being kept under review. This is linked to the development of virtual wards. Mental health services have returned to normal levels of demand. Some pressure remains, and there is a focus on reducing delays to maximise capacity.

Load more